PlenOptika
Allston
About PlenOptika
PlenOptika is a company that spun out from the Massachusetts Institute of Technology and the Madrid–MIT M+Visión Consortium. The founders were research fellows in a biomedical technology innovation initiative who felt compelled to solve the problem of low vision suffered by more than 1 billion people worldwide. Their mission is to make eye care easy for anyone who needs it in the United States, and accessible to underserved and low-resource communities worldwide. PlenOptika has been recognized by international social innovation foundations and business plan competitions. They have collaborated with research centers in the United States, Spain, and India to develop their groundbreaking technology, QuickSee.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $300.0K
- Funding stage: Seed
- Last round: Seed (Jan 2023)
- Website: plenoptika.com
- Phone: +1 617 862 2203
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/plenoptika-110358 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.